Jack Wang
Amministratore Delegato presso Winhealth Pharma Group Co. Ltd.
Posizioni attive di Jack Wang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Winhealth Pharma Group Co. Ltd.
 Winhealth Pharma Group Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Winhealth Pharma Group Co. Ltd. is a Chinese innovative biomedical company founded in 2006, providing novel breakthrough therapies to patients with rare diseases and other unmet medical needs. The company is based in Hangzhou, China. Winhealth Pharma Group has established long-term strategic partnerships with dozens of world-leading biotechnology companies, including Roche, Pfizer, Kyowa Kirin, Shionogi, Cumberland Pharmaceutical, and Daiichi-Sankyo. It has built a unique, balanced, and diversified portfolio with numerous orphan drugs and specialty products at commercial and late clinical stages, and will continuously look to bring in more innovative therapies from the globe. The company was founded in 2006 by Cherry Hu and Jack Wang. Jack Wang has been the CEO since 2006. | Amministratore Delegato | 01/01/2006 | - |
| Presidente | 01/01/2006 | - | |
| Fondatore | 01/01/2006 | - |
Storia della carriera di Jack Wang
Statistiche
Distribuzione geografica
| Cina | 2 |
Posizioni
| Chief Executive Officer | 1 |
| Chairman | 1 |
| Founder | 1 |
Settori
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Winhealth Pharma Group Co. Ltd.
Winhealth Pharma Group Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Winhealth Pharma Group Co. Ltd. is a Chinese innovative biomedical company founded in 2006, providing novel breakthrough therapies to patients with rare diseases and other unmet medical needs. The company is based in Hangzhou, China. Winhealth Pharma Group has established long-term strategic partnerships with dozens of world-leading biotechnology companies, including Roche, Pfizer, Kyowa Kirin, Shionogi, Cumberland Pharmaceutical, and Daiichi-Sankyo. It has built a unique, balanced, and diversified portfolio with numerous orphan drugs and specialty products at commercial and late clinical stages, and will continuously look to bring in more innovative therapies from the globe. The company was founded in 2006 by Cherry Hu and Jack Wang. Jack Wang has been the CEO since 2006. | Commercial Services |
- Borsa valori
- Insiders
- Jack Wang
- Esperienza
